The IPO Buzz: NeurAxis IPO Raises $6.6 Million
NeurAxis Inc. (NRXS), the manufacturer of the IB-Stim pain relief device to help IBS patients ages 11-18, raised $6.59 million by pricing its IPO at $6.00, as expected. The medical device maker announced its IPO pricing today (Wednesday, Aug. 9, 2023) – within an hour of when its stock was expected to make its trading […]
August 9, 2023 Read More